These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15851912)
1. Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population. Ma L; Dudoit Y; Tran T; Xing H; Chen J; Pancino G; Bismuth G; Debré P; Shao Y; Theodorou I; Capoulade-Métay C J Acquir Immune Defic Syndr; 2005 May; 39(1):38-43. PubMed ID: 15851912 [TBL] [Abstract][Full Text] [Related]
2. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia. Capoulade-Métay C; Ma L; Truong LX; Dudoit Y; Versmisse P; Nguyen NV; Nguyen M; Scott-Algara D; Barré-Sinoussi F; Debré P; Bismuth G; Pancino G; Theodorou I AIDS; 2004 Nov; 18(17):2243-52. PubMed ID: 15577536 [TBL] [Abstract][Full Text] [Related]
3. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection]. Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836 [TBL] [Abstract][Full Text] [Related]
4. Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5. Dong HF; Wigmore K; Carrington MN; Dean M; Turpin JA; Howard OM Genes Immun; 2005 Oct; 6(7):609-19. PubMed ID: 16015368 [TBL] [Abstract][Full Text] [Related]
5. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073 [TBL] [Abstract][Full Text] [Related]
6. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan. Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918 [TBL] [Abstract][Full Text] [Related]
7. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function. Howard OM; Shirakawa AK; Turpin JA; Maynard A; Tobin GJ; Carrington M; Oppenheim JJ; Dean M J Biol Chem; 1999 Jun; 274(23):16228-34. PubMed ID: 10347178 [TBL] [Abstract][Full Text] [Related]
8. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Quillent C; Oberlin E; Braun J; Rousset D; Gonzalez-Canali G; Métais P; Montagnier L; Virelizier JL; Arenzana-Seisdedos F; Beretta A Lancet; 1998 Jan; 351(9095):14-8. PubMed ID: 9433423 [TBL] [Abstract][Full Text] [Related]
9. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198 [TBL] [Abstract][Full Text] [Related]
10. South African mutations of the CCR5 coreceptor for HIV modify interaction with chemokines and HIV Envelope protein. Folefoc AT; Fromme BJ; Katz AA; Flanagan CA J Acquir Immune Defic Syndr; 2010 Aug; 54(4):352-9. PubMed ID: 20442662 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. Kuhmann SE; Platt EJ; Kozak SL; Kabat D J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222 [TBL] [Abstract][Full Text] [Related]
12. The molecular cloning and functional expression of the dog CCR5. Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of naturally occurring mutations in the open reading frame of CCR5 in HIV-infected Chinese patients and healthy controls. Zhao XY; Lee SS; Wong KH; Chan KC; Ng F; Chan CC; Han D; Yam WC; Yuen KY; Ng MH; Zheng BJ J Acquir Immune Defic Syndr; 2005 Apr; 38(5):509-17. PubMed ID: 15793360 [TBL] [Abstract][Full Text] [Related]
14. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha. Maeda Y; Foda M; Matsushita S; Harada S J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351 [TBL] [Abstract][Full Text] [Related]
15. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection. Li H; Liu TJ; Hong ZH Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919 [TBL] [Abstract][Full Text] [Related]
16. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals. Mikawa AY; Tagliavini SA; Costa PI Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633 [TBL] [Abstract][Full Text] [Related]
17. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production. Yang JY; Togni M; Widmer U Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873 [TBL] [Abstract][Full Text] [Related]
18. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287. Youn BS; Yu KY; Alkhatib G; Kwon BS Biochem Biophys Res Commun; 2001 Mar; 281(3):627-33. PubMed ID: 11237703 [TBL] [Abstract][Full Text] [Related]
19. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Lehner T Trends Immunol; 2002 Jul; 23(7):347-51. PubMed ID: 12103354 [No Abstract] [Full Text] [Related]
20. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]